Why the study?
Is the ACTN3 gene R577X polymorphism associated with ultra-endurance performance in Ironman triathletes?
Is the ACTN3 gene R577X polymorphism associated with ultra-endurance performance in Ironman triathletes?
The ACTN3 R577X polymorphism does not appear to confer an advantage for ultra-endurance performance in Ironman triathlons.
Answers are grounded in this paper and cite their sources.
No association of ACTN3 R577X with Ironman performance; leaves open its role in other endurance phenotypes or populations.
Alpha-actinins are major structural components of the Z-discs in skeletal muscle. Alpha-actinin 3 is encoded by the ACTN3 gene and is expressed only in type II muscle fibres. Homozygosity for the nonsense mutation, 577X, within ACTN3 results in deficiency of alpha-actinin-3 but does not result in an abnormal muscular phenotype. Previous research has found an association of the 577R allele with sprinting and/or power performance. It has also been suggested that the 577X allele may confer an advantage during endurance events. Four hundred and fifty seven Caucasian male triathletes who completed either the 2000 and/or 2001 226 km South African Ironman Triathlons, and 143 Caucasian controls, were genotyped for the R577X mutation within the ACTN3 gene. There were no significant differences in either the genotype (P = 0.486) or allele (P = 0.375) frequencies within the fastest, middle of the field or slowest Caucasian male finishers and the control population. In conclusion, the R577X polymorphism within the ACTN3 gene was not associated with ultra-endurance performance in the 2000 and 2001 South African Ironman Triathlons.
No takes yet. Share an insight, caveat, or question.
Saunders et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: